CRISPR Therapeutics' current $5.6B market cap and $1.78B net cash position offer acquisition appeal. Click to know why CRSP ...
YouTube on MSN
Her sickle cell pain crises stopped after CRISPR - now the FDA has approved that treatment for patients as young as 2
A lifetime of sudden, crushing pain had already damaged Victoria Gray’s heart and repeatedly sent her to the emergency r ...
We'll know a little more about the company's prospects by the end of the year.
Yesterday (May 4th), Crispr Therapeutics AG (CRSP), the Swiss-based, commercial-stage CRISPR gene editing pioneer, announced its Q1 2026 earnings. The company reported $1m of collaboration revenue and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious ...
“In the end, the Federal Circuit faces a momentous decision: Affirm the PTAB’s status as an apparent international outlier—thereby denying the Nobel Prize winners—or reverse the PTAB, which can be ...
This year, the biotech stock has underperformed both the Nasdaq Biotechnology Index and the S&P 500.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results